Paper387221
Mechanism of action of cis-dichlorodiammineplatinum(II).
Zwelling LA and 1 other. Cancer Treat Rep, 1979. Cited by 223 papers, by iCite.
Cite this record
ConductScience Library. Mechanism of action of cis-dichlorodiammineplatinum(II). Papers, record 387221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/387221
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Binding Sites | |
| Cross-Linking Reagents | |
| DNA | |
| DNA Repair | |
| Humans | |
| Neoplasms | |
| Structure-Activity Relationship |
Source PubMed
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42199066 | Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets. | Ann Med | 2026 | https://conductscience.org/library/papers/42199066 | PubMed |
| 39106540 | Repair of genomic interstrand crosslinks. | DNA Repair (Amst) | 2024 | https://conductscience.org/library/papers/39106540 | PubMed |
| 37554969 | Alkylation of nucleobases by 2-chloro-N,N-diethylethanamine hydrochloride (CDEAH) sensitizes PARP1-deficient tumors. | NAR Cancer | 2023 | https://conductscience.org/library/papers/37554969 | PubMed |
| 33622870 | Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo. | In Vivo | 2021 | https://conductscience.org/library/papers/33622870 | PubMed |
| 31221747 | A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31221747 | PubMed |
| 27754384 | Metabolomic Profiling of the Effects of Melittin on Cisplatin Resistant and Cisplatin Sensitive Ovarian Cancer Cells Using Mass Spectrometry and Biolog Microarray Technology. | Metabolites | 2016 | https://conductscience.org/library/papers/27754384 | PubMed |
| 27253174 | Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial. | Br J Cancer | 2016 | https://conductscience.org/library/papers/27253174 | PubMed |
| 26427828 | Usefulness of Pseudocontinuous Arterial Spin-Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period. | AJNR Am J Neuroradiol | 2016 | https://conductscience.org/library/papers/26427828 | PubMed |
| 26004625 | Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. | Expert Opin Ther Targets | 2015 | https://conductscience.org/library/papers/26004625 | PubMed |
| 25880539 | A metabolomic approach to identifying platinum resistance in ovarian cancer. | J Ovarian Res | 2015 | https://conductscience.org/library/papers/25880539 | PubMed |
| 25264741 | Combinatorial measurement of CDKN1A/p21 and KIF20A expression for discrimination of DNA damage-induced clastogenicity. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25264741 | PubMed |
| 24699359 | Protein quantitative trait loci identify novel candidates modulating cellular response to chemotherapy. | PLoS Genet | 2014 | https://conductscience.org/library/papers/24699359 | PubMed |
| 24133631 | A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma. | Cancer Med | 2013 | https://conductscience.org/library/papers/24133631 | PubMed |
| 24086737 | Endoplasmic reticulum stress is involved in the response of human laryngeal carcinoma cells to Carboplatin but is absent in Carboplatin-resistant cells. | PLoS One | 2013 | https://conductscience.org/library/papers/24086737 | PubMed |
| 24066670 | Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin. | J Transl Med | 2013 | https://conductscience.org/library/papers/24066670 | PubMed |
| 23090015 | Identification and characterization of a 66-68-kDa protein as a methotrexate-binding protein in murine leukemia L1210 cells. | Cell Stress Chaperones | 2013 | https://conductscience.org/library/papers/23090015 | PubMed |
| 22986709 | Polymorphic transporters and platinum pharmacodynamics. | Drug Metab Pharmacokinet | 2013 | https://conductscience.org/library/papers/22986709 | PubMed |
| 22691365 | Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents. | J Ovarian Res | 2012 | https://conductscience.org/library/papers/22691365 | PubMed |
| 22459901 | Contribution of tumoral and host solute carriers to clinical drug response. | Drug Resist Updat | 2012 | https://conductscience.org/library/papers/22459901 | PubMed |
| 20815774 | Overcoming platinum resistance in ovarian carcinoma. | Expert Opin Investig Drugs | 2010 | https://conductscience.org/library/papers/20815774 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/387221
GET https://conductscience.org/api/papers/v1/387221/cited_by?page=2